OBI Pharma Inc (台灣浩鼎) yesterday said it is to give an oral presentation about its new breast cancer vaccine, OBI-822, at the annual meeting of the American Society of Clinical Oncology (ASCO) in June.
The company, which received a notice from ASCO late on Wednesday, said ASCO is among the world’s largest and most influential professional organizations representing physicians of all oncology specialties providing care for cancer patients.
With more than 40,000 members, the organization reviews about 5,800 submissions each year, and OBI Pharma’s OBI-822 is among only 3.8 percent of submissions that have been selected for an oral presentation this year, the company said.
However, OBI Pharma chairman Michael Chang (張念慈) said that ASCO’s selection has little commercial implication for the company’s new treatment.
“ASCO’s selection is by no means an endorsement for the new drug, and will not affect the progress of ongoing clinical trials and regulatory approval, apart from a much-needed boost to morale among our employees,” Chang said at a press conference.
OBI Pharma has been embroiled in controversy since Feb. 21, when it announced that the results of its second and third-phase clinical trials of OBI-822 showed “no statistical significance.”
Since then, OBI Pharma shares have plummeted by nearly 40 percent from this year’s high of NT$719 on Feb. 19 to NT$351 at the end of Wednesday’s session.
The shares were suspended for trading on the Taipei Exchange to conform with regulatory guidelines at a time of disclosing material information.
Academia Sinica President Wong Chi-huey (翁啟惠), a close collaborator with the company, has also come under fire since it was revealed that his daughter, Wong Yu-shioh (翁郁秀), had sold a portion of her holdings in OBI Pharma on Feb. 18, just before prices went spiraling downward.
The Chinese-language Apple Daily yesterday reported that Wong Chi-huey had authorized the stock sale with his daughter’s stock broker at E.Sun Securities Co (玉山證券).
Regarding the allegations, Chang said that the company employs industry-standard protocols, where clinical trial information is handled and compartmentalized by external organizations.
“There were no instances of information leakage, and the allegations of insider trading using non-public information are unfounded,” Chang said, adding that Wong Chi-huey did not know of the discouraging clinical trial results until about two hours before the company held a press conference on Feb. 21.
However, Chang was unable to explain how Wong Chi-huey was able to authorize the stock sale on behalf of his daughter.
Wong Chi-huey had previously pledged that he did not hold any biotechnology stock positions.
“The company had instructed board members, managers and employees to halt all stock trades for one month prior to Feb. 21, but we had failed to include Wong Chi-huey and the company regrets the oversight,” Chang said.
US PUBLICATION: The results indicated a change in attitude after a 2023 survey showed 55 percent supported full-scale war to achieve unification, the report said More than half of Chinese were against the use of force to unify with Taiwan under any circumstances, a survey conducted by the Atlanta, Georgia-based Carter Center and Emory University found. The survey results, which were released on Wednesday in a report titled “Sovereignty, Security, & US-China Relations: Chinese Public Opinion,” showed that 55.1 percent of respondents agreed or somewhat agreed that “the Taiwan problem should not be resolved using force under any circumstances,” while 24.5 percent “strongly” or “somewhat” disagreed with the statement. The results indicated a change in attitude after a survey published in “Assessing Public Support for (Non)Peaceful Unification
The CIA has a message for Chinese government officials worried about their place in Chinese President Xi Jinping’s (習近平) government: Come work with us. The agency released two Mandarin-language videos on social media on Thursday inviting disgruntled officials to contact the CIA. The recruitment videos posted on YouTube and X racked up more than 5 million views combined in their first day. The outreach comes as CIA Director John Ratcliffe has vowed to boost the agency’s use of intelligence from human sources and its focus on China, which has recently targeted US officials with its own espionage operations. The videos are “aimed at
‘MISGUIDED EDICT’: Two US representatives warned that Somalia’s passport move could result in severe retaliatory consequences and urged it to reverse its decision Minister of Foreign Affairs Lin Chia-lung (林佳龍) has ordered that a special project be launched to counter China’s “legal warfare” distorting UN Resolution 2758, a foreign affairs official said yesterday. Somalia’s Civil Aviation Authority on Wednesday cited UN Resolution 2758 and Mogadishu’s compliance with the “one China” principle as it banned people from entering or transiting in the African nation using Taiwanese passports or other Taiwanese travel documents. The International Air Transport Association’s system shows that Taiwanese passport holders cannot enter Somalia or transit there. The Ministry of Foreign Affairs (MOFA) protested the move and warned Taiwanese against traveling to Somalia or Somaliland
SECURITY: Grassroots civil servants would only need to disclose their travel, while those who have access to classified information would be subject to stricter regulations The government is considering requiring legislators and elected officials to obtain prior approval before traveling to China to prevent Chinese infiltration, an official familiar with national security said yesterday. President William Lai (賴清德) in March announced 17 measures to counter China’s growing infiltration efforts, including requiring all civil servants to make trips to China more transparent so they can be held publicly accountable. The official said that the government is considering amending the Act Governing Relations Between the People of the Taiwan Area and Mainland Area (臺灣地區與大陸地區人民關係條例) to require all civil servants to follow strict regulations before traveling to China.